ES2055745T3 - Compuestos antigestagenicos y antiestrogenos para el tratamiento de tumores hormono-dependientes. - Google Patents

Compuestos antigestagenicos y antiestrogenos para el tratamiento de tumores hormono-dependientes.

Info

Publication number
ES2055745T3
ES2055745T3 ES88730222T ES88730222T ES2055745T3 ES 2055745 T3 ES2055745 T3 ES 2055745T3 ES 88730222 T ES88730222 T ES 88730222T ES 88730222 T ES88730222 T ES 88730222T ES 2055745 T3 ES2055745 T3 ES 2055745T3
Authority
ES
Spain
Prior art keywords
hormone
treatment
antigestagenic
dependent tumors
antiestrogen compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88730222T
Other languages
English (en)
Spanish (es)
Inventor
Martin Dr Schneider
Walter Dr Elger
Sybille Dr Beier
Marianne Fahnrich
Beate Kosub
Krzysztof Dr Chwalisz
Syed Hamiduddin Dr Hasan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2055745T3 publication Critical patent/ES2055745T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES88730222T 1987-10-01 1988-09-30 Compuestos antigestagenicos y antiestrogenos para el tratamiento de tumores hormono-dependientes. Expired - Lifetime ES2055745T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873733478 DE3733478A1 (de) 1987-10-01 1987-10-01 Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore

Publications (1)

Publication Number Publication Date
ES2055745T3 true ES2055745T3 (es) 1994-09-01

Family

ID=6337559

Family Applications (2)

Application Number Title Priority Date Filing Date
ES88730222T Expired - Lifetime ES2055745T3 (es) 1987-10-01 1988-09-30 Compuestos antigestagenicos y antiestrogenos para el tratamiento de tumores hormono-dependientes.
ES88730221T Expired - Lifetime ES2053795T3 (es) 1987-10-01 1988-09-30 Compuestos con efecto antigestageno y antiestrogeno para la induccion de un embarazo y para la interrupcion de un embarazo, asi como para el tratamiento de trastornos ginecologicos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES88730221T Expired - Lifetime ES2053795T3 (es) 1987-10-01 1988-09-30 Compuestos con efecto antigestageno y antiestrogeno para la induccion de un embarazo y para la interrupcion de un embarazo, asi como para el tratamiento de trastornos ginecologicos.

Country Status (14)

Country Link
US (2) US4888331A (enExample)
EP (1) EP0310541B1 (enExample)
JP (2) JP2620333B2 (enExample)
AT (2) ATE106730T1 (enExample)
AU (2) AU616208B2 (enExample)
CA (2) CA1330039C (enExample)
DE (3) DE3733478A1 (enExample)
DK (2) DK550088A (enExample)
ES (2) ES2055745T3 (enExample)
GR (1) GR3007225T3 (enExample)
IE (2) IE65165B1 (enExample)
IL (2) IL87886A (enExample)
PH (1) PH26774A (enExample)
ZA (2) ZA887378B (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
DE4329344A1 (de) * 1993-08-27 1995-03-02 Schering Ag Progesteronantagonistisch- und antiöstrogen wirksame Verbindungen für die Behandlung des Leiomyomata uteri
DE4335876A1 (de) * 1993-10-17 1995-04-20 Schering Ag Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
GB9410533D0 (en) * 1994-05-26 1994-07-13 Lynxvale Ltd In situ hybridisation and immuno-Chemical localisation of a growth factor
DE4426601A1 (de) * 1994-07-27 1996-02-01 Schering Ag Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
DE19706061A1 (de) 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
US6653297B1 (en) * 1997-07-03 2003-11-25 Medical College Of Hampton Roads Control of selective estrogen receptor modulators
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6509334B1 (en) * 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6399593B1 (en) * 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
EP1173213A1 (en) * 1999-05-04 2002-01-23 American Home Products Corporation Compositions containing benzimidazolones and progestogens
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
SI1173210T1 (en) * 1999-05-04 2005-02-28 Wyeth Contraceptive compositions containing antiprogestinic and progestinic
US6380178B1 (en) * 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6355648B1 (en) * 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
ATE301129T1 (de) 1999-05-04 2005-08-15 Strakan Int Ltd Androgen glykoside und die androgenische aktivität davon
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
JP2004510994A (ja) * 2000-10-06 2004-04-08 バイオメディシンズ，インコーポレイティド エストロゲン−感受性疾病の処理のための組み合わせ治療
DE60115274T2 (de) * 2000-10-18 2006-07-27 Schering Ag Verwendung von antiprogestinen zur prophylaxe und behandlung von hormonabhängigen erkrankungen
US6599921B2 (en) 2001-02-22 2003-07-29 Nanodesign, Inc. Non-steroidal estrogen receptor ligands
UY27301A1 (es) * 2001-05-25 2003-02-28 Schering Ag Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata
US20030013694A1 (en) * 2001-05-25 2003-01-16 Jens Hoffmann Use and compositions of antiprogestins for treatment of prostate diseases
GB0120147D0 (en) * 2001-08-17 2001-10-10 Metris Therapeutics Ltd Treatment method
DE10159217A1 (de) * 2001-11-27 2003-06-05 Schering Ag 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
EP1603563A4 (en) * 2003-02-28 2007-08-22 Morgan Lee R RESONANCE MODULATOR FOR DIAGNOSIS AND THERAPY
US20040242551A1 (en) * 2003-05-28 2004-12-02 Schering Ag Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
US8685950B2 (en) * 2004-10-04 2014-04-01 Wayne State University Use of aromatase inhibitors for treatment of ectopic pregnancy
WO2008019048A1 (en) * 2006-08-04 2008-02-14 Meditrina Pharmaceuticals Use of aromatase inhibitors for thining the endometrium or treating menorrhagia
US7694688B2 (en) 2007-01-05 2010-04-13 Applied Materials, Inc. Wet clean system design
WO2009075838A2 (en) * 2007-12-10 2009-06-18 Meditrina Pharmaceuticals, Inc. Treatment of menorrhagia with aromatase inhibitor
US20100087402A1 (en) * 2008-09-29 2010-04-08 Vivus, Inc. Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656187A (en) * 1981-08-03 1987-04-07 Eli Lilly And Company Treatment of mammary cancer
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
DE3323321A1 (de) * 1983-06-24 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Prophylaxe und therapie von koronaren herzkrankheiten durch senkung des oestrogenspiegels
DE3337450A1 (de) * 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
US4666885A (en) * 1985-02-08 1987-05-19 Fernand Labrie Combination therapy for treatment of female breast cancer
US4775660A (en) * 1984-08-02 1988-10-04 Fernand Labrie Treatment of breast cancer by combination therapy
IE58836B1 (en) * 1984-08-02 1993-11-17 Labrie Fernand Pharmaceutical composition for combination therapy of hormone dependent cancers
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
US4732904A (en) * 1984-12-24 1988-03-22 Morgan Lee R Antiestrogenic hydrazones
DE3533175A1 (de) * 1985-09-13 1987-03-19 Schering Ag Antigestagene zur verschiebung der endometrialen reifung
FR2598083B1 (fr) * 1986-05-05 1989-12-29 Theramex Laboratoire Nouvelles compositions pharmaceutiques a action antiprogesteronique et leur procede d'obtention
DE3633244A1 (de) * 1986-09-26 1988-03-31 Schering Ag Antigestagene zur hemmung der uterinen prostaglandinsynthese

Also Published As

Publication number Publication date
AU616208B2 (en) 1991-10-24
AU2332288A (en) 1989-06-08
IE66335B1 (en) 1995-12-27
IE65165B1 (en) 1995-10-04
JP2656958B2 (ja) 1997-09-24
IE882954L (en) 1989-04-01
US5733902A (en) 1998-03-31
US4888331A (en) 1989-12-19
ZA887378B (en) 1989-05-30
ATE106730T1 (de) 1994-06-15
JPH01106822A (ja) 1989-04-24
IL87885A0 (en) 1989-03-31
CA1329126C (en) 1994-05-03
DE3733478A1 (de) 1989-04-13
AU624082B2 (en) 1992-06-04
IL87885A (en) 1993-06-10
GR3007225T3 (enExample) 1993-07-30
ATE83149T1 (de) 1992-12-15
IL87886A (en) 1993-06-10
DE3850026D1 (de) 1995-07-06
AU2332188A (en) 1989-04-20
CA1330039C (en) 1994-06-07
DK550188D0 (da) 1988-09-30
JPH01106823A (ja) 1989-04-24
DE3876582D1 (de) 1993-01-21
EP0310541A1 (de) 1989-04-05
EP0310541B1 (de) 1992-12-09
PH26774A (en) 1992-09-28
ES2053795T3 (es) 1994-08-01
DK550088A (da) 1989-04-02
DK550188A (da) 1989-04-02
DK550088D0 (da) 1988-09-30
JP2620333B2 (ja) 1997-06-11
IE882953L (en) 1989-04-01
IL87886A0 (en) 1989-03-31
ZA887379B (en) 1989-05-30

Similar Documents

Publication Publication Date Title
ES2055745T3 (es) Compuestos antigestagenicos y antiestrogenos para el tratamiento de tumores hormono-dependientes.
FI873363A0 (fi) Foerfarande foer framstaellning av laekemedel med antitumoeraktivitet.
ES2133270T3 (es) Terapia de combinacion para la profilaxis y/o el tratamiento de hiperplasia prostatica benigna.
AR244492A1 (es) Composicion fungicida mejorada para el tratamiento de la madera.
DE3887151D1 (de) Inhibitoren für zellenzuwachs und methoden für krebsbehandlung.
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
DK0500602T3 (da) Middel til neutralisering af til tumorceller knyttet prokoagulantaktivitet
DE3672283D1 (de) Konditionierungsmittel fuer die behandlung von basismaterialien.
ES2037670T3 (es) Procedimiento para la preparacion de complejos de (2,2-bis(aminometil)-1,3-propanodiol-n,n') platino.
ATE58900T1 (de) Diaryldiazolylmethane.
ES532696A0 (es) Procedimiento para el tratamiento de textiles
BR8700447A (pt) Agente preventivo de endurecimento para fertilizante
ES465215A1 (es) Procedimiento para la preparacion de compuestos poliomeri- cos.
ES538040A0 (es) Procedimiento para preparar compuesto de adicion apropiados como agentes dispersantes.
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
ES8801624A1 (es) Procedimiento para preparar disulfuros heterociclicos
BR8001832A (pt) Agente para o tratamento de couros e calcados, com brilho proprio
ES2019583B3 (es) Composicion para el tratamiento de infecciones.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
ES487297A0 (es) Procedimiento e instalacion para el tratamiento termico de material mineral,en especial para calcinar yeso
MX9203715A (es) Preparciones para el tratamiento del tejido aloinjertado.
SU1075674A1 (ru) 2,3,2,3-Тетрагидро-3,3-тетрацианметилен-5,5-бис-as-триазин, обладающий противовоспалительной и анальгетической активностью
ES2025787T3 (es) Procedimiento de tratamiento de madera.
ES510720A0 (es) Maquina para el tratamiento de granos.
ES512871A0 (es) "procedimiento para el tratamiento de desperdicios".

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 310542

Country of ref document: ES